Hemiplegic migraine
ICD-10 G43.4 · ICD-11 8A80.10

What Is the Treatment of Hemiplegic Migraine? First-Line Approach

This page outlines the first-line management approach for hemiplegic migraine, covering treatment of mild to moderate attacks and the key clinical target: meaningful pain relief within 2 hours.

Clinical Goal

The primary objective of treatment is reduction of headache — ideally complete freedom from pain — within 2 hours of taking the initial medication.

Treatment Approach

Mild to moderate attacks are managed initially with oral analgesic or anti-inflammatory agents. When nausea or vomiting accompanies the attack, anti-emetic therapy is incorporated into the regimen.

The full protocol details the complete sequence of agents, contraindication pathways, combination strategies, and dosing options — see the link below.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1177/2514183X1882337

Analgesics like acetylsalicylic acid and non-steroidal anti-inflammatory drugs (NSAIDs) are effective in the treatment of migraine.

Mild and moderate migraine attacks should be treated initially with these substances.

Anti-emetics like metoclopramide or domperidone are effective in the treatment of nausea and vomiting during a migraine attack.

The reduction of headache after 2 h, the most important parameter in clinical studies for the efficacy of migraine medications, is greatest following subcutaneous administration of sumatriptan (70–80%).

View source ↗